#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA720015	F	Percent inhibition of convulsions in audiogenic DBA/2 mice at dose 20 mg/kg	Mus musculus	6	ALA1131053	organism-based format	Scientific Literature
2.	ALA780515	F	Inhibitory effect against veratridine-induced glutamate release from rat brain slices	Rattus norvegicus	33	ALA1135973	assay format	Scientific Literature
3.	ALA787012	F	Percent inhibition of veratridine-induced glutamate release in rat brain slices at 10000 nmol/L; ND is No Data.	Rattus norvegicus	4	ALA1135973	tissue-based format	Scientific Literature
4.	ALA789319	F	Neuroprotective activity was determined in the rat middle cerebral artery occlusion (MCAO) model of focal stroke	Rattus norvegicus	13	ALA1134457	organism-based format	Scientific Literature
5.	ALA806327	B	In vitro inhibition of [14C]- guanidinium influx in Chinese hamster ovary (CHO) cells expressing rat brain sodium channel type IIA (CNaIIA-1)	Rattus norvegicus	12	ALA1131053	cell-based format	Scientific Literature
6.	ALA818548	B	Inhibition of [3H]BTX binding to cardiac voltage-gated sodium channel	Rattus norvegicus	15	ALA1134457	assay format	Scientific Literature
7.	ALA845816	B	Displacement of [3H]BTX from sodium channel of rat cerebral cortex synaptosomes	Rattus norvegicus	33	ALA1135973	subcellular format	Scientific Literature
8.	ALA844979	B	Displacement of [3H]-MK-801 from rat cerebral cortex glutamate NMDA receptor; ND is No Data.	Rattus norvegicus	3	ALA1135973	tissue-based format	Scientific Literature
9.	ALA1027763	A	Volume of distribution at steady state in human	Homo sapiens	5	ALA1158480	organism-based format	Scientific Literature
10.	ALA1028540	A	Volume of distribution at steady state in human administered three way cross over study in 11, 10 and 12 healthy subjects at 5, 10, 15 mg dose respectively as 1 hr infusion	Homo sapiens	1	ALA1158480	organism-based format	Scientific Literature
11.	ALA1028541	A	Clearance in human administered three way cross over study in 11, 10 and 12 healthy subjects at 5, 10, 15 mg dose respectively as 1 hr infusion	Homo sapiens	1	ALA1158480	organism-based format	Scientific Literature
12.	ALA1028542	A	Mean residence time in human administered three way cross over study in 11, 10 and 12 healthy subjects at 5, 10, 15 mg dose respectively as 1 hr infusion	Homo sapiens	1	ALA1158480	organism-based format	Scientific Literature
13.	ALA1028543	A	Half life in human administered three way cross over study in 11, 10 and 12 healthy subjects at 5, 10, 15 mg dose respectively as 1 hr infusion	Homo sapiens	1	ALA1158480	organism-based format	Scientific Literature
14.	ALA1028544	A	Volume of distribution at steady state in human given 31 administration across 6 doses 2.5 to 25 mg administered 30 mins infusion each dose separated by 13 days	Homo sapiens	1	ALA1158480	organism-based format	Scientific Literature
15.	ALA1028545	A	Clearance in human given 31 administration across 6 doses 2.5 to 25 mg administered 30 mins infusion each dose separated by 13 days	Homo sapiens	1	ALA1158480	organism-based format	Scientific Literature
16.	ALA1028546	A	Mean residence time in human given 31 administration across 6 doses 2.5 to 25 mg administered 30 mins infusion each dose separated by 13 days	Homo sapiens	1	ALA1158480	organism-based format	Scientific Literature
17.	ALA1028547	A	Half life in human given 31 administration across 6 doses 2.5 to 25 mg administered 30 mins infusion each dose separated by 13 days	Homo sapiens	1	ALA1158480	organism-based format	Scientific Literature
18.	ALA2416952	F	Cytotoxicity against human A2780 cells after 72 hrs by MTT assay	Homo sapiens	3	ALA2413002	cell-based format	Scientific Literature
19.	ALA2416953	F	Cytotoxicity against human A549 cells after 72 hrs by MTT assay	Homo sapiens	3	ALA2413002	cell-based format	Scientific Literature
20.	ALA2416954	F	Antiproliferative activity against human A2780 cells at 0.005 uM after 72 hrs by MTT assay	Homo sapiens	1	ALA2413002	cell-based format	Scientific Literature